PT1753440E - Forma de administração oral contendo bactérias probióticas - Google Patents

Forma de administração oral contendo bactérias probióticas Download PDF

Info

Publication number
PT1753440E
PT1753440E PT05746643T PT05746643T PT1753440E PT 1753440 E PT1753440 E PT 1753440E PT 05746643 T PT05746643 T PT 05746643T PT 05746643 T PT05746643 T PT 05746643T PT 1753440 E PT1753440 E PT 1753440E
Authority
PT
Portugal
Prior art keywords
probiotic bacteria
administration containing
oral form
containing probiotic
oral
Prior art date
Application number
PT05746643T
Other languages
English (en)
Inventor
Stefan Henke
Markus Rudolph
Iris Manneck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34980007&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1753440(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PT1753440E publication Critical patent/PT1753440E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PT05746643T 2004-05-28 2005-05-04 Forma de administração oral contendo bactérias probióticas PT1753440E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004026706A DE102004026706A1 (de) 2004-05-28 2004-05-28 Orale Darreichungsform enthaltend probiotische Bakterien

Publications (1)

Publication Number Publication Date
PT1753440E true PT1753440E (pt) 2008-05-28

Family

ID=34980007

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05746643T PT1753440E (pt) 2004-05-28 2005-05-04 Forma de administração oral contendo bactérias probióticas

Country Status (20)

Country Link
US (2) US20090162322A1 (pt)
EP (1) EP1753440B1 (pt)
JP (1) JP5070043B2 (pt)
KR (1) KR101289413B1 (pt)
CN (1) CN1956724B (pt)
AT (1) ATE386534T1 (pt)
AU (1) AU2005249187B2 (pt)
BR (1) BRPI0511615B8 (pt)
CA (1) CA2568171C (pt)
CY (1) CY1107399T1 (pt)
DE (2) DE102004026706A1 (pt)
DK (1) DK1753440T3 (pt)
ES (1) ES2299034T3 (pt)
MX (1) MXPA06013686A (pt)
PL (1) PL1753440T3 (pt)
PT (1) PT1753440E (pt)
RU (1) RU2376023C2 (pt)
SI (1) SI1753440T1 (pt)
WO (1) WO2005117921A1 (pt)
ZA (1) ZA200610768B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697126B2 (en) * 2005-05-18 2014-04-15 Dsm Ip Assets B.V. Compositions for enternal application of microorganisms
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
DK2839836T3 (en) * 2006-10-02 2017-12-04 Dupont Nutrition Biosci Aps Probiotics for use in reducing symptoms of respiratory disease
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US8834853B2 (en) 2009-08-14 2014-09-16 DuPont Nutrition BioScience ApS Coated dehydrated microorganisms with enhanced stability and viability
KR20130045855A (ko) 2010-03-12 2013-05-06 칼피스가부시키가이샤 대장에 있어서의 비피더스균의 증가 및 감소억제제
EP2705140B8 (de) 2011-05-06 2018-04-25 Belano Medical AG Neue milchsäurebakterien und diese enthaltende zusammensetzungen
RU2651466C2 (ru) 2011-05-16 2018-04-19 ОРГАНОБАЛАНС Медикал АГ Новые молочнокислые бактерии и содержащие их составы против бактериальных простудных заболеваний
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
US10588857B2 (en) 2012-03-29 2020-03-17 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
RU2491079C1 (ru) * 2012-07-13 2013-08-27 Федеральное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Комплексный пробиотический препарат и способ его получения
TWI481409B (zh) * 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
JP6464142B2 (ja) 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
US10849940B2 (en) * 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
KR101470995B1 (ko) * 2013-08-30 2014-12-09 주식회사 바이오리쏘스 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
US10799541B2 (en) 2014-07-01 2020-10-13 Probi USA, Inc. Bi-layer dual release probiotic tablets
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
US10339273B2 (en) 2015-11-18 2019-07-02 Warsaw Orthopedic, Inc. Systems and methods for pre-operative procedure determination and outcome predicting
CN111870617B (zh) * 2019-11-04 2022-06-10 深圳碳云智能数字生命健康管理有限公司 肠道益生菌补剂配方的确定方法、装置、存储介质及处理器
CN111110703B (zh) * 2020-01-13 2020-12-01 华中农业大学 动物双歧杆菌及其制备的复合菌制剂在制备治疗或预防禽流感病毒感染的药物中的应用
CN114917259B (zh) * 2022-02-15 2023-10-13 中国科学院上海硅酸盐研究所 一种二维氢硅烯-微生物复合材料及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58157726A (ja) * 1982-03-11 1983-09-19 Shin Etsu Chem Co Ltd 固形薬剤用腸溶性コ−テイング剤組成物
JPH024016A (ja) * 1988-06-20 1990-01-09 Fujitsu Ltd 半導体集積回路
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IT1265092B1 (it) * 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
CN1156271C (zh) * 2000-04-29 2004-07-07 中国科学技术大学 一种固体药剂用高分子包衣粉及其制备方法
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist
CA2439078C (en) * 2001-03-09 2009-08-25 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation

Also Published As

Publication number Publication date
US20190110997A1 (en) 2019-04-18
CA2568171C (en) 2013-09-17
KR101289413B1 (ko) 2013-08-07
RU2006145056A (ru) 2008-07-10
CN1956724A (zh) 2007-05-02
KR20070024539A (ko) 2007-03-02
AU2005249187B2 (en) 2011-03-17
CA2568171A1 (en) 2005-12-15
BRPI0511615A (pt) 2008-01-02
AU2005249187A1 (en) 2005-12-15
ZA200610768B (en) 2008-07-30
EP1753440A1 (de) 2007-02-21
CY1107399T1 (el) 2012-12-19
PL1753440T3 (pl) 2008-05-30
EP1753440B1 (de) 2008-02-20
DE102004026706A1 (de) 2005-12-15
JP2008500294A (ja) 2008-01-10
RU2376023C2 (ru) 2009-12-20
DE502005002929D1 (de) 2008-04-03
SI1753440T1 (sl) 2008-08-31
CN1956724B (zh) 2013-08-28
MXPA06013686A (es) 2007-02-13
ATE386534T1 (de) 2008-03-15
ES2299034T3 (es) 2008-05-16
DK1753440T3 (da) 2008-06-02
BRPI0511615B8 (pt) 2021-05-25
US20090162322A1 (en) 2009-06-25
WO2005117921A1 (de) 2005-12-15
BRPI0511615B1 (pt) 2018-01-23
JP5070043B2 (ja) 2012-11-07

Similar Documents

Publication Publication Date Title
PL1753440T3 (pl) Forma do podawania doustnego zawierająca bakterie probiotyczne
PH12014502880A1 (en) Lyophilized therapeutic peptibody formulations
EP1919302B8 (en) Food comprising silicon
LUC00065I2 (pt)
TW200700009A (en) Active compound combinations having insecticidal and acaricidal properties
PL1663168T3 (pl) Preparaty nikotyny i ich zastosowanie
EP1859022A4 (en) NEW SAFETY TOLERANT LACTOBACILLUS SAKEI PROBIO-65 WITH THE CAPACITY TO SUPPORT GROWTH-BASED MICRO-ORGANISMS AND ANTI-ALLERGIC EFFECTS
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
PL1869161T3 (pl) Sposób wytwarzania niealergizujących hodowli bakterii probiotycznych i ich zastosowanie
MX2007005202A (es) Polisacaridos de estreptococo modificados y usos de los mismos.
ATE407215T1 (de) Enzymatische demethylierung von flavonoiden
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MY148276A (en) Long-term feed- elderly
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
AU316238S (en) Lawning applicator for microbiological cultures
WO2010036344A8 (en) Compositions, oral care products and methods of making and using the same
WO2007081455A3 (en) Induction of a physiological dispersion response in bacterial cells in a biofilm
DK1633373T3 (da) Farmaceutisk sammensætning indeholdende glucan hidrørende fra mikroalger
TW200613604A (en) Preparation of fabrics having lotus leaf effect and fabrics having lotus leaf effect
SG151171A1 (en) Association between an anti-atherothrombotic and an angiotensin- converting enzyme inhibitor
PL1687014T3 (pl) Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi
NZ587553A (en) A new class of chloroflexi-iike thermophilic cellulose degrading bacteria
AU319802S (en) Plenum spacer 1
AU316107S (en) Blower pulleys